2019 (65 POSTS)
Rogers JM , Watanabe M. 2019. Editorial: Special issue on “Developmental effects of smoking, vaping, and cannabis use.” Birth Defects Res 111(17):1245–1247; doi: 10.1002/bdr2.1596 . PMID: 31566934.
View Abstract
Topics: Cannabinoid/Industrial Hemp
Yoon M, Ring C, Van Landingham CB, Suh M , Song G, Antonijevic T, Gentry PR, Taylor MD, Keen AM, Andersen ME, Clewell JH. 2019. Assessing children’s exposure to manganese in drinking water using a PBPK model. Toxicol Appl Pharmacol 380(Oct 1):114695; doi: 10.1016/j.taap.2019.114695 . PMID: 31394159.
View Abstract
Topics: Exposure Assessment , Manganese , Metals , modeling , PBPK/PBDE , water
Bylsma LC , Dean R, Lowe K, Sangaré L, Alexander DD, Fryzek JP. 2019. The incidence of infusion reactions associated with monoclonal antibody drugs targeting the epidermal growth factor receptor in metastatic colorectal cancer patients: A systematic literature review and meta‐analysis of patient and study characteristics. Cancer Med 8(12):5800–5809; doi: 10.1002/cam4.2413 . PMID: 31376243.
View Abstract
Topics: Cancer , meta-analysis , Systematic Review
Thompson CM , Fitch SE , Ring C, Rish W , Cullen JM, Haws LC . 2019. Development of an oral reference dose for the perfluorinated compound GenX. J Appl Toxicol 39(9):1267–1282; doi: 10.1002/jat.3812 . PMID: 31215065.
View Abstract
Topics: benchmark dose estimation (BMD) , PFAS , water
Wikoff D , Haws L , Ring C, Budinsky R. 2019. Application of qualitative and quantitative uncertainty assessment tools in developing ranges of plausible toxicity values for 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin. J Appl Toxicol 39(9):1293-1310; doi: 10.1002/jat.3814 . PMID: 31257608.
View Abstract
Topics: dioxin , risk assessment
Frankenfeld CL , Leslie TF. 2019. Descriptive epidemiology of homicides with victim and suspect race or Hispanic ethnicity discordance in the United States: Analysis of National Violent Death Reporting System (NVDRS) 2005-2015. J Interpers Violence 36(17-18):NP9693–NP9173; doi: 10.1177/0886260519861656 . PMID: 31288601.
View Abstract
Topics: community health , Epidemiology
Hoff CE, Movva N , Rosen Vollmar AK, Pérez-Escamilla R. 2019. Impact of maternal anxiety on breastfeeding outcomes: A systematic review. Advanc Nutr 10(5):816-826; doi: 10.1093/advances/nmy132 . PMID: 31079143.
View Abstract
Topics: nutrition , Systematic Review
Nordyke RJ, Reichert H , Bylsma LC , Jackson JJ, Gage SM, Fryzek J, Roy-Chaudhury P, Lithgow T. 2019. Costs attributable to arteriovenous fistula and arteriovenous graft placements in hemodialysis patients with Medicare coverage. Am J Nephrol 50(4):320-328; doi: 10.1159/000502507 . PMID: 31434095.
View Abstract
Topics: Health Economics and Outcomes Research (HEOR)
Bussiere JL, Davies R, Dean C, Xu C, Kim KH, Vargas HM, Chellman GJ, Balasubramanian G, Monticello TM . 2019. Nonclinical safety evaluation of erenumab, a CGRP receptor inhibitor for the prevention of migraine. Regul Toxicol Pharmacol 106(Aug):224-238; doi: 10.1016/j.yrtph.2019.05.013 . PMID: 31085251.
View Abstract
Topics: nonclinical safety assessment
Webster F, Gagne M, Patlewicz G , Pradeep P, Trefiak N, Judson R, Barton-Maclaren TS. 2019. Predicting estrogen receptor activation by a group of substituted phenols: An integrated approach to testing and assessment case study. Regul Toxicol Pharmacol 106(Aug):278-291; doi: 10.1016/j.yrtph.2019.05.017 . PMID: 31121201.
View Abstract
Topics: NAMs
Patlewicz G , Lizarraga L, Rua D, Allen DG, Daniel A, Fitzpatrick SC, Garcia-Reyero N, Gordon J, et al. 2019. Exploring current read-across applications and needs among selected US federal agencies. Regul Toxicol Pharmacol 106(Aug):197-209; doi: 10.1016/j.yrtph.2019.05.011 . PMID: 31078681.
View Abstract
Topics: NAMs
Danese MD, Katz A, Cetin K, Chia V, Gleeson ML, Kelsh M , et al. 2019. Treatment patterns, survival, and hospitalization in adult patients with acute lymphoblastic leukemia: An observational cohort study using SEER Medicare data. Leuk Lymphoma 60(8):2015–2024; doi: 10.1080/10428194.2018.1555329 . PMID: 30632830.
View Abstract
Topics: Cancer
Andersen ME, Gentry PR, Swenberg JA, Mundt KA, White KW, Thompson C , Bus J, Sherman JH, et al. 2019. Considerations for refining the risk assessment process for formaldehyde: Results from an interdisciplinary workshop. Regul Toxicol Pharmacol 106(Aug):210–223; doi: 10.1016/j.yrtph.2019.04.015 . PMID: 31059732.
View Abstract
Topics: formaldehyde , risk assessment
Prior H, Monticello T , Boulifard V, Brennan FR, Kimber I. 2019. Integration of consortia recommendations for justification of animal use within current and future drug development paradigms. Int J Toxicol 38(4):319-325; doi: 10.1177/1091581819852922 . PMID: 31220983.
View Abstract
Topics: drug development , safety assessment
Frankenfeld CL , Leslie TF. 2019. County-level socioeconomic factors and residential racial, Hispanic, poverty, and unemployment segregation associated with drug overdose deaths in the United States, 2010–2015. Ann Epidemiol 35(July):12–19; doi: 10.1016/j.annepidem.2019.04.009 . PMID: 31080000.
View Abstract
Topics: community health , Epidemiology
Klaren WD , Ring C, Harris MA, Thompson CM , Borghoff S , Sipes NS, Hsieh JH, Auerbach SS, Rager JE. 2019. Identifying attributes that influence in vitro-to-in vivo concordance by comparing Tox21 bioactivity versus DrugMatrix transcriptomic responses across 130 chemicals. Toxicol Sci 167(1):157–171; doi: 10.1093/toxsci/kfy220 . PMID: 30202884.
View Abstract